Tetanus Toxoid (TT) in Pregnancy

Tetanus toxoid doses administered during pregnancy under India's Maternal and Child Health programme to prevent maternal and neonatal tetanus, particularly in areas where deliveries may occur outside hospitals.

The Tetanus Toxoid (TT) in Pregnancy is recommended for 16 weeks (TT1), 20 weeks (TT2, or booster if previously immunised). It falls under the Pregnancy vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The Tetanus Toxoid (TT) in Pregnancy has an efficacy of 95–100%. This means it provides significant protection against Maternal Tetanus and Neonatal Tetanus. Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Mild pain and swelling at injection site. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The Tetanus Toxoid (TT) in Pregnancy should be avoided by: Severe allergy to a previous tetanus toxoid dose. Always inform your healthcare provider of your full medical history before vaccination.

The Tetanus Toxoid (TT) in Pregnancy typically costs ₹25 – ₹100 in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.